A group of experts who reviewed evidence on urinary tract infections (UTIs) failed to come up with many recommendations due ...

Pain while peeing, the urgent need to "go," frequent urination… the telltale signs of urinary tract infections (UTIs)-caused ...

If you’re one of the many people in the world who experiences recurrent UTIs, you may be seeking natural and alternative ... for treating UTIs. One older study of 57 women found that ...

The pain and discomfort of recurrent urinary tract infections (UTIs) and cystitis could be relieved by a natural preventative ...

The FDA approved oral sulopenem etzadroxil and probenecid (Orlynvah) to treat uncomplicated urinary tract infections (uUTIs) ...

Urinary tract infections are common, especially, though not exclusively, in women, and the risk generally increases with age.

FDA approved Orlynvah for the Tx of uncomplicated urinary tract infections caused by Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis.

A mild UTI may last days or under a week. These are sometimes called uncomplicated UTIs. Learn how long a complicated UTI ...

The US Food and Drug Administration (FDA) approved a new oral antibiotic to treat uncomplicated urinary tract infections ...

The Food and Drug Administration has approved Iterum Therapeutics' Orlynvah, the first drug of its kind, which is designed to ...

The drug, Orlynvah, treats uncomplicated urinary tract infections in adult women and will be available around mid-2025. Also in the news: chemotherapy, Ottimo Pharma, a blood-sugar monitoring app, and ...

The treatment has been shown to be active against third generation cephalosporin-resistant Enterobacterales species. Orlynvah combines sulopenem etzadroxil, a penem antibacterial drug, and ...